Brother Enterprises Holding Co Ltd (002562) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Brother Enterprises Holding Co Ltd (002562) has a cash flow conversion efficiency ratio of 0.014x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥52.13 Million ≈ $7.63 Million USD) by net assets (CN¥3.68 Billion ≈ $538.47 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Brother Enterprises Holding Co Ltd - Cash Flow Conversion Efficiency Trend (2008–2024)
This chart illustrates how Brother Enterprises Holding Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 002562 total debt and obligations for a breakdown of total debt and financial obligations.
Brother Enterprises Holding Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Brother Enterprises Holding Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Resolute Holdings Management, Inc.
NYSE:RHLD
|
1.433x |
|
Firefly Metals Ltd
AU:FFM
|
-0.012x |
|
Priortech
TA:PRTC
|
-0.002x |
|
Asiana Airline
KO:020560
|
-0.033x |
|
ASBISc Enterprises PLC
WAR:ASB
|
0.015x |
|
Alphamin Resources Corp
F:21L
|
N/A |
|
Ningbo Peace Bird Fashion
SHG:603877
|
0.044x |
|
China Reinsurance (Group) Corporation
F:C53
|
0.065x |
Annual Cash Flow Conversion Efficiency for Brother Enterprises Holding Co Ltd (2008–2024)
The table below shows the annual cash flow conversion efficiency of Brother Enterprises Holding Co Ltd from 2008 to 2024. For the full company profile with market capitalisation and key ratios, see Brother Enterprises Holding Co Ltd market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥3.10 Billion ≈ $453.58 Million |
CN¥124.90 Million ≈ $18.28 Million |
0.040x | +150.14% |
| 2023-12-31 | CN¥3.05 Billion ≈ $446.91 Million |
CN¥49.20 Million ≈ $7.20 Million |
0.016x | -64.01% |
| 2022-12-31 | CN¥3.37 Billion ≈ $493.60 Million |
CN¥151.00 Million ≈ $22.10 Million |
0.045x | +294.42% |
| 2021-12-31 | CN¥3.00 Billion ≈ $438.31 Million |
CN¥-68.96 Million ≈ $-10.09 Million |
-0.023x | -141.40% |
| 2020-12-31 | CN¥3.03 Billion ≈ $442.90 Million |
CN¥-28.87 Million ≈ $-4.22 Million |
-0.010x | +76.59% |
| 2019-12-31 | CN¥2.32 Billion ≈ $339.03 Million |
CN¥-94.41 Million ≈ $-13.82 Million |
-0.041x | -131.41% |
| 2018-12-31 | CN¥2.26 Billion ≈ $330.54 Million |
CN¥293.09 Million ≈ $42.89 Million |
0.130x | +140.85% |
| 2017-12-31 | CN¥2.29 Billion ≈ $334.44 Million |
CN¥123.13 Million ≈ $18.02 Million |
0.054x | -19.89% |
| 2016-12-31 | CN¥1.76 Billion ≈ $258.15 Million |
CN¥118.64 Million ≈ $17.36 Million |
0.067x | -49.58% |
| 2015-12-31 | CN¥1.71 Billion ≈ $249.50 Million |
CN¥227.43 Million ≈ $33.28 Million |
0.133x | +22.36% |
| 2014-12-31 | CN¥838.59 Million ≈ $122.71 Million |
CN¥91.42 Million ≈ $13.38 Million |
0.109x | -27.86% |
| 2013-12-31 | CN¥799.95 Million ≈ $117.06 Million |
CN¥120.87 Million ≈ $17.69 Million |
0.151x | -19.83% |
| 2012-12-31 | CN¥791.30 Million ≈ $115.79 Million |
CN¥149.14 Million ≈ $21.82 Million |
0.188x | +268.20% |
| 2011-12-31 | CN¥859.77 Million ≈ $125.81 Million |
CN¥-96.34 Million ≈ $-14.10 Million |
-0.112x | -162.81% |
| 2010-12-31 | CN¥281.78 Million ≈ $41.23 Million |
CN¥50.27 Million ≈ $7.36 Million |
0.178x | -32.21% |
| 2009-12-31 | CN¥231.15 Million ≈ $33.82 Million |
CN¥60.82 Million ≈ $8.90 Million |
0.263x | -38.34% |
| 2008-12-31 | CN¥190.34 Million ≈ $27.85 Million |
CN¥81.23 Million ≈ $11.89 Million |
0.427x | -- |
About Brother Enterprises Holding Co Ltd
Brother Enterprises Holding Co.,Ltd. engages in the research, development, production, and sale of fine chemicals in China and internationally. The company offers vitamin supplements, such as vitamin K3, vitamin B1, nicotinamide, niacin, vitamin B5, and aminopropionic acid; chrome tanning agents, retanning agents, fatliquoring agents, and auxiliaries; and contrast agent APIs and intermediates, to… Read more